Home

2011 Press Releases

Keyword Search
 
2014 | 2013 | 2012 | 2011 | 2010 | 2009
Investor Resources
TNGN(Common Stock)
ExchangeOTC BB (US Dollar)
Price$0.18
Change (%)0.00 (0.00%)
Volume0
Data as of 07/22/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
What's New
December 13, 2011
Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting
Highlights Include Additional Cell Characterization Supporting the Neo-Urinary Conduit™ and New Biomaterial Testing for the Neo-Kidney Augment™ Program EAST NORRITON, Pa., Dec. 13, 2011 /PRNewswire/ -- Tengion, Inc. (NASDAQ: TNGN), a leader in regenerative medicine, today announced that new data from the Company's Neo-Urinary Conduit™ (NUC) and Neo-Kidney Augment™ (NUC) programs are featured in several presentations at the TERMIS North America Annual Conference being held Dece... 
December 05, 2011
Tengion Appoints John L. Miclot President and Chief Executive Officer
EAST NORRITON, Pa,, Dec. 5, 2011 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, today announced the appointment of John L. Miclot as its President and Chief Executive Officer. Most recently, Mr. Miclot was an Executive-in-Residence at Warburg Pincus.  He was President and Chief Executive Officer of CCS Medical, Inc., a company owned by Warburg Pincus and a provider of products and services for patients with chronic diseases, from 2008 until completion of a fin...